|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray and Bray F:
Cancer incidence and mortality worldwide: Sources, methods and
major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Patel SS, Shah KA, Shah MJ, Kothari KC and
Rawal RM: Cancer stem cells and stemness markers in oral squamous
cell carcinomas. Asian Pac J Cancer Prev. 15:8549–8556. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Liu WL, Tang DC, Chen L, Wang M,
Pack SD, Zhuang Z and Rodgers GP: Identification and
characterization of a novel member of olfactomedin-related protein
family, hGC-1, expressed during myeloid lineage development. Gene.
283:83–93. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oue N, Sentani K, Noguchi T, Ohara S,
Sakamoto N, Hayashi T, Anami K, Motoshita J, Ito M, Tanaka S, et
al: Serum olfacto-medin 4 (GW112, hGC-1) in combination with Reg IV
is a highly sensitive biomarker for gastric cancer patients. Int J
Cancer. 125:2383–2392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo Z, Zhang Q, Zhao Z, Li B, Chen J and
Wang Y: OLFM4 is associated with lymph node metastasis and poor
prognosis in patients with gastric cancer. J Cancer Res Clin Oncol.
137:1713–1720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kobayashi D, Koshida S, Moriai R, Tsuji N
and Watanabe N: Olfactomedin 4 promotes S-phase transition in
proliferation of pancreatic cancer cells. Cancer Sci. 98:334–340.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen L, Li H, Liu W, Zhu J, Zhao X, Wright
E, Cao L, Ding I and Rodgers GP: Olfactomedin 4 suppresses prostate
cancer cell growth and metastasis via negative interaction with
cathepsin D and SDF-1. Carcinogenesis. 32:986–994. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li H, Liu W, Chen W, Zhu J, Deng CX and
Rodgers GP: Olfactomedin 4 deficiency promotes prostate neoplastic
progression and is associated with upregulation of the
hedgehog-signaling pathway. Sci Rep. 5:169742015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kulkarni NH, Karavanich CA, Atchley WR and
Anholt RR: Characterization and differential expression of a human
gene family of olfactomedin-related proteins. Genet Res. 76:41–50.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu RH, Yang MH, Xiang H, Bao LM, Yang HA,
Yue LW, Jiang X, Ang N, Wu LY and Huang Y: Depletion of OLFM4 gene
inhibits cell growth and increases sensitization to hydrogen
peroxide and tumor necrosis factor-alpha induced-apoptosis in
gastric cancer cells. J Biomed Sci. 19:382012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Zhu J, Cao L and Rodgers GP:
Expression of hGC-1 is correlated with differentiation of gastric
carcinoma. Histopathology. 51:157–165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Besson D, Pavageau AH, Valo I, Bourreau A,
Bélanger A, Eymerit-Morin C, Moulière A, Chassevent A,
Boisdron-Celle M, Morel A, et al: A quantitative proteomic approach
of the different stages of colorectal cancer establishes OLFM4 as a
new nonmet-astatic tumor marker. Mol Cell Proteomics.
10:M111.009712. 2011. View Article : Google Scholar
|
|
13
|
Zhang X, Huang Q, Yang Z, Li Y and Li CY:
GW112, a novel antiapoptotic protein that promotes tumor growth.
Cancer Res. 64:2474–2481. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mitani Y, Oue N, Matsumura S, Yoshida K,
Noguchi T, Ito M, Tanaka S, Kuniyasu H, Kamata N and Yasui W: Reg
IV is a serum biomarker for gastric cancer patients and predicts
response to 5-fluorouracil-based chemotherapy. Oncogene.
26:4383–4393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun YW, Chen KM, Imamura Kawasawa Y,
Salzberg AC, Cooper TK, Caruso C, Aliaga C, Zhu J, Gowda K, Amin S
and El-Bayoumy K: Hypomethylated Fgf3 is a potential biomarker for
early detection of oral cancer in mice treated with the tobacco
carcinogen dibenzo[def,p]chrysene. PLoS One. 12:e01868732017.
View Article : Google Scholar
|
|
16
|
Umair A, Tarakji B, Ibrahim A, Nasser A,
Fq A and Shreen A: Quantitative study of epigenetic signature in
head and neck squamous cell carcinoma. Turk J Med Sci. 45:372–386.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Foy JP, Pickering CR, Papadimitrakopoulou
VA, Jelinek J, Lin SH, William WN Jr, Frederick MJ, Wang J, Lang W,
Feng L, et al: New DNA methylation markers and global DNA
hypomethylation are associated with oral cancer development. Cancer
Prev Res (Phila). 8:1027–1035. 2015. View Article : Google Scholar
|
|
18
|
Bakhtiar SM, Ali A and Barh D: Epigenetics
in head and neck cancer. Methods Mol Biol. 1238:751–769. 2015.
View Article : Google Scholar
|
|
19
|
Prawdzic Senkowska A, Kiczmer P,
Strzelczyk JK, Kowalski D, Krakowczyk Ł and Ostrowska Z: Impact of
HPV infection on gene expression and methylation in oral cancer
patients. J Med Microbiol. 68:440–445. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou C, Shen Z, Ye D, Li Q, Deng H, Liu H
and Li J: The Association and clinical significance of CDKN2A
promoter methylation in head and neck squamous cell carcinoma: A
meta-analysis. Cell Physiol Biochem. 50:868–882. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mydlarz WK, Hennessey PT, Wang H, Carvalho
AL and Califano JA: Serum biomarkers for detection of head and neck
squamous cell carcinoma. Head Neck. 38:9–14. 2016. View Article : Google Scholar
|
|
22
|
Shi H, Chen X, Lu C, Gu C, Jiang H, Meng
R, Niu X, Huang Y and Lu M: Association between P16INK4a promoter
methylation and HNSCC: A meta-analysis of 21 published studies.
PLoS One. 10:e01223022015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao J, Shu P, Duan F, Wang X, Min L, Shen
Z, Ruan Y, Qin J, Sun Y and Qin X: Loss of OLFM4 promotes tumor
migration through inducing interleukin-8 expression and predicts
lymph node metastasis in early gastric cancer. Oncogenesis.
5:e2342016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jang BG, Lee BL and Kim WH:
Olfactomedin-related proteins 4 (OLFM4) expression is involved in
early gastric carcinogenesis and of prognostic significance in
advanced gastric cancer. Virchows Arch. 467:285–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barnes L, Eveson J, Reichart P and
Sidransky D: World Health Organization classifications tumours.
Pathology and genetics of head and neck tumours Lyon: IARC;
2005
|
|
26
|
Rangan SR: A new human cell line (FaDu)
from a hypopharyngeal carcinoma. Cancer. 29:117–121. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peterson WD Jr, Stulberg CS, Swanborg NK
and Robinson AR: Glucose-6-phosphate dehydrogenase isoenzymes in
human cell cultures determined by sucrose-agar gel and cellulose
acetate zymograms. Proc Soc Exp Biol Med. 128:772–776. 1968.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou Y and Hu Z: Epigenetic DNA
demethylation causes inner ear stem cell differentiation into hair
cell-like cells. Front Cell Neurosci. 10:1852016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van der Flier LG, Haegebarth A, Stange DE,
van de Wetering M and Clevers H: OLFM4 is a robust marker for stem
cells in human intestine and marks a subset of colorectal cancer
cells. Gastroenterology. 137:15–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamazaki H, Mori T, Yazawa M, Maeshima AM,
Matsumoto F, Yoshimoto S, Ota Y, Kaneko A, Tsuda H and Kanai Y:
Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck
squamous cell carcinoma: Clues for diagnosis. Lab Invest.
93:1331–1338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Castilho RM, Squarize CH and Almeida LO:
Epigenetic modifications and Head and neck cancer: Implications for
tumor progression and resistance to therapy. Int J Mol Sci. 18:pii:
E1506. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schuijers J, van der Flier LG, van Es J
and Clevers H: Robust cre-mediated recombination in small
intestinal stem cells utilizing the olfm4 locus. Stem Cell Reports.
3:234–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ziskin JL, Dunlap D, Yaylaoglu M, Fodor
IK, Forrest WF, Patel R, Ge N, Hutchins GG, Pine JK, Quirke P, et
al: In situ validation of an intestinal stem cell signature in
colorectal cancer. Gut. 62:1012–1023. 2013. View Article : Google Scholar
|
|
34
|
Liu W, Liu Y, Zhu J, Wright E, Ding I and
Rodgers GP: Reduced hGC-1 protein expression is associated with
malignant progression of colon carcinoma. Clin Cancer Res.
14:1041–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gersemann M, Becker S, Nuding S, Antoni L,
Ott G, Fritz P, Oue N, Yasui W, Wehkamp J and Stange EF:
Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD.
J Crohns Colitis. 6:425–434. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marimuthu A, Chavan S, Sathe G,
Sahasrabuddhe NA, Srikanth SM, Renuse S, Ahmad S, Radhakrishnan A,
Barbhuiya MA, Kumar RV, et al: Identification of head and neck
squamous cell carcinoma biomarker candidates through proteomic
analysis of cancer cell secretome. Biochim Biophys Acta.
1834:2308–2316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Grover PK, Hardingham JE and Cummins AG:
Stem cell marker olfactomedin 4: Critical appraisal of its
characteristics and role in tumorigenesis. Cancer Metastasis Rev.
29:761–775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu W, Li H, Hong SH, Piszczek GP, Chen W
and Rodgers GP: Olfactomedin 4 deletion induces colon
adenocarcinoma in ApcMin/+ mice. Oncogene. 35:5237–5247.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sentani K, Sakamoto N, Shimamoto F, Anami
K, Oue N and Yasui W: Expression of olfactomedin 4 and claudin-18
in serrated neoplasia of the colorectum: A characteristic pattern
is associated with sessile serrated lesion. Histopathology.
62:1018–1027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamanoi K, Arai E, Tian Y, Takahashi Y,
Miyata S, Sasaki H, Chiwaki F, Ichikawa H, Sakamoto H, Kushima R,
et al: Epigenetic clustering of gastric carcinomas based on DNA
meth-ylation profiles at the precancerous stage: Its correlation
with tumor aggressiveness and patient outcome. Carcinogenesis.
36:509–520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guo LL, He ZC, Yang CQ, Qiao PT and Yin
GL: Epigenetic silencing of olfactomedin-4 enhances gastric cancer
cell invasion via activation of focal adhesion kinase signaling.
BMB Rep. 48:630–635. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Su W, Luo L, Wu F, Lai Z, Li X, Xie Z,
Tang Z, Yang Z and Liang R: Low expression of olfactomedin 4
correlates with poor prognosis in smoking patients with non-small
cell lung cancer. Hum Pathol. 46:732–738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takadate T, Onogawa T, Fukuda T, Motoi F,
Suzuki T, Fujii K, Kihara M, Mikami S, Bando Y, Maeda S, et al:
Novel prognostic protein markers of resectable pancreatic cancer
identified by coupled shotgun and targeted proteomics using
formalin-fixed paraffin-embedded tissues. Int J Cancer.
132:1368–1382. 2013. View Article : Google Scholar
|
|
44
|
Ogata K, Aihara R, Mochiki E, Ogawa A,
Yanai M, Toyomasu Y, Ando H, Ohno T, Asao T and Kuwano H: Clinical
significance of melanoma antigen-encoding gene-1 (MAGE-1)
expression and its correlation with poor prognosis in
differentiated advanced gastric cancer. Ann Surg Oncol.
18:1195–1203. 2011. View Article : Google Scholar
|
|
45
|
Zhang S, Zhou X, Yu H and Yu Y: Expression
of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer
tissues and cell lines. BMC Cancer. 10:1632010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou SJ, Zhuo SR, Yang XQ, Qin CX and Wang
ZL: Serum Dickkopf-1 expression level positively correlates with a
poor prognosis in breast cancer. Diagn Pathol. 9:1612014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shi Y, Gong HL, Zhou L, Tian J and Wang Y:
Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous
cell carcinoma. Acta Otolaryngol. 134:753–759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dong LL, Qu LY, Chu LY, Zhang XH and Liu
YH: Serum level of DKK-1 and its prognostic potential in non-small
cell lung cancer. Diagn Pathol. 9:522014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen C, Zhou H, Zhang X, Ma X, Liu Z and
Liu X: Elevated levels of Dickkopf-1 are associated with β-catenin
accumulation and poor prognosis in patients with chondrosarcoma.
PLoS One. 9:e1054142014. View Article : Google Scholar
|
|
50
|
Huang Y, Yang X, Zhao F, Shen Q, Wang Z,
Lv X, Hu B, Yu B, Fan J and Qin W: Overexpression of Dickkopf-1
predicts poor prognosis for patients with hepatocellular carcinoma
after ortho-topic liver transplantation by promoting cancer
metastasis and recurrence. Med Oncol. 31:9662014. View Article : Google Scholar
|
|
51
|
Tao YM, Liu Z and Liu HL: Dickkopf-1
(DKK1) promotes invasion and metastasis of hepatocellular
carcinoma. Dig Liver Dis. 45:251–257. 2013. View Article : Google Scholar
|
|
52
|
Jiang T, Huang L and Zhang S: DKK-1 in
serum as a clinical and prognostic factor in patients with cervical
cancer. Int J Biol Markers. 28:221–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
